<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:pp="http://www.presspage.com/rss/"
     version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom">
                <channel>
                    <title><![CDATA[OSF HealthCare Newsroom]]></title>
                    <link>https://newsroom.osfhealthcare.org/</link>
                    <description></description>
                    <language>en-us</language>
                    <lastBuildDate>Mon, 26 Oct 2026 03:46:31 +0100</lastBuildDate>
                    <pubDate>Thu, 27 Aug 2026 21:25:10 +0200</pubDate>
                    <image>
                        <title><![CDATA[OSF HealthCare Newsroom]]></title>
                        <url>https://content.presspage.com/clients/150_1873.png</url>
                        <link>https://newsroom.osfhealthcare.org/</link>
                        <width>144</width>
                    </image><item>
                        <title>EKOS: A game changer in treating blood clots</title>
                        <link>https://newsroom.osfhealthcare.org/ekos-a-game-changer-in-treating-blood-clots/</link>
                        <guid>https://newsroom.osfhealthcare.org/ekos-a-game-changer-in-treating-blood-clots/</guid><pp:caseid>789398</pp:caseid><pp:summary><![CDATA[<p><strong>Key Takeaways: </strong></p><ul><li class="ck-list-marker-bold" data-list-item-id="e2e52f3a436e0d070ad71a2ed3171ca66"><strong>Ekosonic Endovascular System (EKOS) is a minimally invasive procedure used to treat blood clots. </strong></li><li class="ck-list-marker-bold" data-list-item-id="e83cde72067a7307acb513ee959ab83b4"><strong>The technology uses ultrasound waves to break clots into smaller pieces. </strong></li><li class="ck-list-marker-bold" data-list-item-id="e3c28e09d67ea725bed254e1b955d6c33"><strong>EKOS helps treats patients quickly and efficiently within minutes and hours. </strong></li><li class="ck-list-marker-bold" data-list-item-id="ee53c9cf7642796df25489cf782764732"><strong>The EKOS procedure is used for certain clots and doesn't prevent future clots. </strong></li></ul>]]></pp:summary><description><![CDATA[<p>Blood clots are nothing to mess with. But there is a procedure called EKOS that uses ultrasound waves to break up clots before they become life threatening. </p>]]></description><content:encoded><![CDATA[<img src="https://content.presspage.com/uploads/1873/a66d3ddc-27f8-4add-9739-4399d44e0f5e/1920_photoofsurgeryprocedure.jpg?10000"><p><span>A blo</span>od clot can be dangerous. When a clot blocks blood flow to the lungs, it can become a life-threatening emergency.</p><p>For some people with large or complicated blood clots, there’s another treatment option: the Ekosonic Endovascular System (EKOS).</p><p>EKOS is a minimally invasive procedure using ultrasound waves and a clot-dissolving medication breaking down blood clots. The treatment can be used for certain people with pulmonary embolisms, deep vein thrombosis (DVT) and other serious blood clots.</p><p>“If we care for someone with a blood clot that is big enough in the lungs, or a bigger clot in the legs, we insert EKOS,” says <a href="https://www.osfhealthcare.org/providers/monther-el%20bzour-4206942">Monther El Bzour, MD</a>, a cardiologist with OSF HealthCare. “It has a technology that emits ultrasound waves to break the clot into smaller pieces. We also infuse a clot-buster medication called tPA [tissue plasminogen activator]. These two together can help to dissolve the clot in a very fast way, and that helps the patient to feel much better within minutes or hours.”</p><p>During the procedure, a physician guides a small catheter through a blood vessel and positions it near the clot. Ultrasound waves are then delivered through the catheter while a clot-dissolving medication is infused directly into the area. According to Dr. El Bzour, the drug is infused for six to 12 hours. Those treated usually go home within 24 hours if there are no complications.</p><p><strong>Knowing the warning signs</strong></p><p>Pulmonary embolisms and DVTs can cause different symptoms. A pulmonary embolism occurs when a blood clot travels to the lungs. Symptoms can include sudden shortness of breath, chest pain that may become worse with a deep breath, rapid heartbeat or coughing.</p><p>A DVT typically occurs in a deep vein, often in the leg. Symptoms can include swelling, pain or tenderness, warmth or discoloration in the affected leg.</p><p>Not every blood clot requires EKOS. The size, location and severity of the clot, along with the patient's overall condition, help determine the appropriate treatment, says Dr. El Bzour.</p><p>“If you have a blood clot in small veins below the knee, we don't use this technology. If you have smaller blood clots in the lungs and they are in very small arteries, we don't use this technology,” Dr. El Bzour says. “It's only meant to tackle the complicated, the massive blood clots, either in the lung or the leg.”</p><p><strong>EKOS doesn’t prevent future clots</strong></p><p>While EKOS can help treat an existing blood clot, it does not prevent future clots from forming. Many patients will still need blood-thinning medication after treatment, depending on the cause of the clot and their individual medical circumstances.</p><p>“If I can offer you something to feel better quickly, I think we're all for it,” Dr. El Bzour says. “And I can say [EKOS] is a game changer for the management of blood clots.”</p><p>Most importantly, Dr. El Bzour says people should not ignore symptoms that could indicate a dangerous blood clot. “It is a very serious problem, and the quicker you can make it to the emergency room and to a hospital that offer this technology the better outcome and the chance to be alive and feeling better,” he says.</p><p>For more information on cardiovascular services, visit the OSF HealthCare Cardiovascular Institute <a href="https://www.osfhealthcare.org/services/specialties/heart?utm_campaign=m11-369037&utm_source=mly-google&utm_medium=cpc&linksource=m11-369037-mly-google&gad_source=1&gad_campaignid=22858553020&gbraid=0AAAAADgz_lE8ulb4CN4M74tRjPC9CJfXt&gclid=EAIaIQobChMIi_TBwdCtlgMV0YPCCB06czE8EAAYASAAEgInavD_BwE">website</a>.</p><h2><span style="color:hsl(120,75%,60%);">Interview Clips </span></h2><h2><span style="color:hsl(120,75%,60%);">B-Roll</span></h2>]]></content:encoded><category><![CDATA[feature,blood clots,deep vein thrombosis,Pulmonary embolism,EKOS]]></category>
            <pubDate>Thu, 27 Aug 2026 14:25:10 -0500</pubDate>
            <pp:lastModified>Thu, 27 Aug 2026 19:25:10 +0000</pp:lastModified>
            <enclosure url="https://content.presspage.com/uploads/1873/84d321d9-75c3-425e-a559-42af88ff481a/500_womanrubbingleg.jpg?10000" length="0" type="image/jpg" />
                <pp:image>https://content.presspage.com/uploads/1873/84d321d9-75c3-425e-a559-42af88ff481a/500_womanrubbingleg.jpg?10000</pp:image>
                <pp:imageOriginal>https://content.presspage.com/uploads/1873/84d321d9-75c3-425e-a559-42af88ff481a/womanrubbingleg.jpg?10000</pp:imageOriginal><pp:imageTitle><![CDATA[woman rubbing leg]]></pp:imageTitle><pp:imageDescription><![CDATA[stock photo of woman rubbing leg for possible clot]]></pp:imageDescription></item><item>
                        <title>OSF radiologist excited to have new FDA-approved tool to treat pulmonary embolism</title>
                        <link>https://newsroom.osfhealthcare.org/osf-radiologist-excited-to-have-new-fda-approved-tool-to-treat-pulmonary-embolism/</link>
                        <guid>https://newsroom.osfhealthcare.org/osf-radiologist-excited-to-have-new-fda-approved-tool-to-treat-pulmonary-embolism/</guid><pp:caseid>629231</pp:caseid><pp:subtitle>OSF patients participated in the clinical trial leading to new use for the medical device</pp:subtitle><pp:boilerplate><![CDATA[<p style="margin-left:0in;"><span><strong>OSF HealthCare</strong> is an integrated health system founded by The Sisters of the Third Order of St. Francis. Headquartered in Peoria, Illinois, OSF HealthCare has 16 hospitals – 10 acute care, five critical access, one transitional care - with 2,131 licensed beds throughout Illinois and Michigan. OSF employs nearly 24,000 Mission Partners across 150+ locations; has two colleges of nursing; operates OSF Home Care Services, an extensive network of home health and hospice services; owns Pointcore, Inc., comprised of health care-related businesses; OSF HealthCare Foundation, the philanthropic arm for the organization; and OSF Ventures, which provides investment capital for promising health care innovation startups. In 2020, OSF OnCall was established, a digital health operating unit, including a hospital-at-home. OSF OnCall delivers care and services when, where and how patients prefer to receive them. OSF HealthCare has been recognized by Fortune as one of the most innovative companies in the country. More at </span><a href="https://www.osfhealthcare.org/"><span>osfhealthcare.org.&nbsp;&nbsp;</span></a><span>&nbsp;</span></p><p><span><strong>AngioDynamics Inc</strong>. is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life. The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit </span><a href="https://www.angiodynamics.com/"><span>angiodynamics.com</span></a><span>.</span></p>]]></pp:boilerplate><description><![CDATA[<img src="https://content.presspage.com/uploads/1873/8d2caef1-ac24-4783-9695-9f4b05680004/1920_alphavac.png?10000"><p><span>OSF HealthCare patients enrolled in a clinical trial at OSF HealthCare Saint Francis Medical Center in Peoria, Illinois contributed to the recent FDA approval of a medical device to treat patients who develop a pulmonary embolism (PE). A pulmonary embolism is a life-threatening blockage in pulmonary arteries – a condition that device manufacturer </span><a href="https://www.angiodynamics.com/"><span>AngioDynamics</span></a><span> says affects nearly 900,000 people in the United States every year and is this third leading cause of cardiovascular deaths.</span></p><p><span>Prompt treatment greatly reduces the risk of death. OSF Saint Francis was one of 25 hospital-based sites across the country to assess </span><span style="background-color:rgb(254,254,254);"><span>the AlphaVac F18⁸⁵ System for the treatment of PE. Patients who enrolled were those with confirmed acute PE with intermediate risk. Patients with more severe risk are often given the clot-busting drug known as TPA and those with the least risk can receive medication to dissolve the clot without requiring a hospital stay.</span></span></p><p><span>Daniel Gans, MD, a vascular and interventional radiologist was the lead investigator for the clinical trial that included six OSF Saint Francis patients among the 122 nationwide who qualified. The device was previously approved for use in the treatment of blood clots and blockages in other parts of the body. The new approval expands the device’s use in the non-surgical removal of clots in the lung.</span></p><p><span>The study results will be released in May but lead researchers say the results showed the device was effective in safely removing blood clots in the patients’ lungs and increasing right ventricle function in PE patients who did well 48 hours after the procedure. Patients were also followed for a month.</span></p><p><span>Dr. Gans was impressed with the </span><span style="background-color:white;">ergonomic handle</span><span> that he says is an improvement over another similar device that uses mechanical aspiration. The </span><span style="background-color:rgb(254,254,254);"><span>AlphaVac F18⁸⁵ System </span></span><span>is a small, flexible aspirational catheter which can basically vacuum the clot out of the blood vessel. Dr. Gans says because of the design, it’s easier to get to the clot quickly, particularly large central clots, and to have confidence the blockage has been properly dislodged and removed.</span></p><p><span>With future studies that compare the approach to other interventions for PE patients regardless of risk, Dr. Gans thinks the Al</span><span style="background-color:rgb(254,254,254);"><span>phaVac F18⁸⁵ system could prove more effective than using clot busting medication.</span></span></p><p><span style="background-color:rgb(254,254,254);">“I think as time goes on, we’re probably going to find out that it is very effective and may even become the mainstay of therapy for PE,” Dr. Gans suggests. “The FDA clearance is a major milestone in showing this is a </span><span style="background-color:white;">safe and effective option for improving patient outcomes and reducing stress on the heart associated with pulmonary embolism.”</span><span style="background-color:rgb(254,254,254);"><span> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>]]></description><category><![CDATA[news,OSF HealthCare Saint Francis Medical Center,Pulmonary embolism,PE,angiodynamics,AlphaVac F18⁸⁵,Dr. Daniel Gans,interventional radiologist,FDA,FDA-approved,medical device]]></category>
            <pubDate>Mon, 22 Apr 2024 08:00:00 -0500</pubDate>
            <pp:lastModified>Mon, 22 Apr 2024 18:39:53 +0000</pp:lastModified>
            <enclosure url="https://content.presspage.com/uploads/1873/8d2caef1-ac24-4783-9695-9f4b05680004/500_alphavac.png?10000" length="0" type="image/png" />
                <pp:image>https://content.presspage.com/uploads/1873/8d2caef1-ac24-4783-9695-9f4b05680004/500_alphavac.png?10000</pp:image>
                <pp:imageOriginal>https://content.presspage.com/uploads/1873/8d2caef1-ac24-4783-9695-9f4b05680004/alphavac.png?10000</pp:imageOriginal><pp:imageTitle><![CDATA[AlphaVac]]></pp:imageTitle></item><item>
                        <title>Getting a leg up on blood clots</title>
                        <link>https://newsroom.osfhealthcare.org/getting-a-leg-up-on-blood-clots/</link>
                        <guid>https://newsroom.osfhealthcare.org/getting-a-leg-up-on-blood-clots/</guid><pp:caseid>578970</pp:caseid><description><![CDATA[<p>Blood clots are no joke. If not dealt with appropriately they can cause many problems, even death. &nbsp;Former NFL player Deion Sanders recently underwent surgery to remove clots to both legs.&nbsp;</p>]]></description><content:encoded><![CDATA[<img src="https://content.presspage.com/uploads/1873/344bb2b2-f673-4d59-97a6-d0f2e9dfd9ea/1920_deionsanders.jpg?10000"><p><span>During his 14-year career in the NFL, Deion “Prime Time” Sanders was known for his silky moves on the football field. But now the 55-year-old college football coach has been slowed, due in large part to blood clots he’s suffered over the years.</span></p><p><span>Sanders was back in the news recently due to surgery he had on blood clots in both legs. It’s not his first go-around with this serious health issue. In 2021 he had two toes amputated due to clots.</span></p><p><span>Blood clots can happen to anyone. Deep vein thrombosis (DVT) is a blood clot located in a deep vein, usually in a leg or arm. A pulmonary embolism (PE) is a blood clot that has traveled from a deep vein to a lung. According to the Centers for Disease Control and Prevention (CDC), 900,000 people suffer from a blood clot each year and 100,000 people die. About 30% of people who have had a DVT or PE are prone to a recurrence.</span></p><p><span>“It is a serious problem. It's something that you're going to want to seek medical care for," says Dr. Samantha Cox, a vascular surgeon with OSF HealthCare. "The venous blood clots can be fatal, and you may develop a blood clot in your lower extremity, say after a prolonged period where you're sedentary, maybe after prolonged travel, maybe you have a hypercoagulable state or a disease state that puts you for higher risk of developing a blood clot. If that were to travel to your lungs, that's approximately 10% chance of mortality. So, it could be fatal at the time that it's identified.”</span></p><p><span>Risk factors for blood clots vary. They include being older, overweight, a family history, illnesses such as cancer or heart disease, being sedentary due to surgery, confined to a bed or paralysis.</span></p><p><span>About half of people with DVT exhibit no symptoms. For those who do, warning signs include swelling, pain, tenderness or redness of the skin. The same goes for PE. But if you’re experiencing trouble breathing, fast heartbeat, chest pain, coughing blood or light headedness, seek help immediately.</span></p><p><span>“Blood clots are common, especially in an aging population or if you have certain risk factors," says Dr. Cox. "Many patients have no idea that they have an underlying blood clotting disorder. Other people have what we call an acquired thrombotic state or pro thrombotic state; maybe they're a smoker, maybe they're obese or have diabetes, all those things will put them at a slightly increased risk for blood clotting. Also, use of any medications for example, hormonal medications, are known medications that may cause increased risk of blood clotting.”</span></p><p><span>Blood clots can be treated. Many patients are placed on blood thinners long term to prevent future clots. Compression stockings are often recommended to prevent DVT and relieve pain and swelling. In the most serious cases, clots are removed surgically, such as the case with Sanders.&nbsp;</span><br><br><span>And while he avoided amputation this time, Sanders still has a long road to travel.</span></p><p><span>“He will likely require other interventions in the future when someone is coming to the position of having tissue loss or digit loss losing part of their feet or toes that's an organ failure," says Dr. Cox. &nbsp;"Just like we talk about people who have blindness or people who have kidney failure that can't reverse, and they go on to hemodialysis. When you're losing your digits or losing the soft tissue on your feet, or your lower extremities, that's an end organ problem, which is then becoming a chronic problem. So, this will be something that he has to manage for the rest of his life.”</span><br><br><span>To prevent blood clots, Dr. Cox has several recommendations, starting with visiting your physician regularly.</span></p><p><span>“When you start to see a problem develop, when you see a wound or sore discoloration to your feet or your legs, have that checked out by your provider," she says. "Make sure your physicians are aware of that problem. This is not one of those times when you should put your head in the sand and hide. You really want to come to your physicians with that clinical problem and let them work with you to develop an appropriate solution.”</span></p><p><span>For more information, visit </span><a href="https://www.osfhealthcare.org/heart/services/pulmonary-embolism/"><span>OSF HealthCare</span></a><span>.</span></p><h2><span style="color:#27ae60;">Interview Clips&nbsp;</span></h2>]]></content:encoded><category><![CDATA[feature,blood clots,Pulmonary embolism,deep vein thrombosis,Rockford,vascular]]></category>
            <pubDate>Thu, 29 Jun 2023 11:00:00 -0500</pubDate>
            <pp:lastModified>Tue, 11 Jul 2023 15:31:36 +0000</pp:lastModified>
            <enclosure url="https://content.presspage.com/uploads/1873/cb12ed21-2171-4a1a-8462-ce7bf6f05058/500_womanholdingleg.jpg?10000" length="0" type="image/jpg" />
                <pp:image>https://content.presspage.com/uploads/1873/cb12ed21-2171-4a1a-8462-ce7bf6f05058/500_womanholdingleg.jpg?10000</pp:image>
                <pp:imageOriginal>https://content.presspage.com/uploads/1873/cb12ed21-2171-4a1a-8462-ce7bf6f05058/womanholdingleg.jpg?10000</pp:imageOriginal><pp:imageTitle><![CDATA[woman holding leg]]></pp:imageTitle></item></channel>
                    </rss>